Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA.
University of Oxford, John Radcliffe Hospital, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Oxford, United Kingdom.
Surgery. 2019 Nov;166(5):926-933. doi: 10.1016/j.surg.2019.06.003. Epub 2019 Aug 6.
Morbidity and mortality after laparoscopic bariatric surgery have decreased steadily during the past 2 decades. National data on the rates at which these patients may require return to the hospital beyond 30 days are lacking. We aimed to determine the national burden and causes of readmission after the 3 most common bariatric procedures in the United States.
All adult patients with morbid obesity (>18 years old) who underwent a laparoscopic adjustable gastric banding, laparoscopic sleeve gastrectomy, or laparoscopic gastric bypass between 2010 and 2015 were identified using International Classification of Diseases, Ninth Revision codes from the Nationwide Readmission Database. The Nationwide Readmission Database permits longitudinal tracking of patients between hospital admissions and allows for nationally weighted estimates. The primary outcome was 180-day readmission; secondary outcomes included causes, mortality, time to readmission, costs, and procedures during readmission. Multivariate logistic regression models were used to determine factors associated with increased 180-day readmission after adjusting for differences in patient and hospital characteristics.
Records from 228,043 patients were identified, of whom 10.1%, 36.1%, and 53.9% underwent laparoscopic adjustable gastric banding, laparoscopic sleeve gastrectomy, and laparoscopic gastric bypass, respectively. The overall 180-day readmission rate was 10.8% (laparoscopic adjustable gastric banding 8.3%, LGS 7.8% and laparoscopic gastric bypass 13.2%). Readmission analysis showed that 64.5% were directly relates directly to the index procedure, 31.2% were readmitted to a different hospital, the median time to readmission was 28 days (interquartile ratio 9-77), 23.9% had a gastrointestinal procedure, and 0.48% died within the 180-day readmissions. Factors independently associated with increased readmission were the following: greater preoperative comorbidities (Charlson Comorbidity Index ≥2, odds ratio 1.32; 95% confidence interval, 1.22-1.44); either Medicare status (1.84 [1.72-1.97]) or Medicaid status (1.60 [1.48-1.73]) relative to private insurance; moderate (1.09 [1.03-1.15]) or major (1.33 [1.13-1.56]) severity of illness relative to minor Nationwide Readmission Database-provided severity of illness; nonresident of state where they were admitted initially (1.49 [1.31-1.69]); discharge to a health care system other than home (1.70 [1.46-1.97]); short-term hospital 1.70 [1.46-1.97]); admission to private hospital (1.11 [1.01-1.22]) relative to nonprofit hospital; prolonged duration of initial hospital stay (1.81 [1.70-1.92]); and a serious adverse event occurring during the index admission (1.20 [1.02-1.42]). Patients who were readmitted had an incremental mean difference of $15,781 (95% confidence interval, $15,168-$16,394.4; P < .001) in total costs.
Readmissions after bariatric surgery continue to occur even 6 months after discharge. Most of these readmissions were related directly to the index procedure. Almost a fourth of those patients who were readmitted d required a procedure and almost a third presented to a different hospital than the hiatal of their initial operation. These readmissions carry a substantial burden for the health care system and may impair quality of life for patients. Strategies targeted to prevent readmissions beyond the traditional 30-day benchmark are warranted in this population.
在过去的 20 年中,腹腔镜减重手术后的发病率和死亡率稳步下降。缺乏关于这些患者在 30 天后可能需要再次住院的国家数据。我们旨在确定美国最常见的 3 种减重手术后 30 天以上的患者再入院的全国负担和原因。
使用国际疾病分类,第九版代码,从全国再入院数据库中确定了 2010 年至 2015 年期间患有病态肥胖症(>18 岁)的所有接受腹腔镜可调胃带,腹腔镜袖状胃切除术或腹腔镜胃旁路手术的成年患者。全国再入院数据库允许在住院之间对患者进行纵向跟踪,并允许进行全国加权估计。主要结果是 180 天再入院;次要结果包括原因,死亡率,再入院时间,费用和再入院期间的程序。使用多变量逻辑回归模型确定了在调整患者和医院特征差异后与 180 天再入院率增加相关的因素。
确定了 228,043 名患者的记录,其中 10.1%,36.1%和 53.9%分别接受了腹腔镜可调胃带,腹腔镜袖状胃切除术和腹腔镜胃旁路手术。总体 180 天再入院率为 10.8%(腹腔镜可调胃带 8.3%,LGS 7.8%和腹腔镜胃旁路 13.2%)。再入院分析显示,64.5%与指数手术直接相关,31.2%被送往不同的医院,中位再入院时间为 28 天(四分位距 9-77),23.9%进行了胃肠道手术,0.48%在 180 天内再入院时死亡。与再入院率增加相关的独立因素包括:术前合并症更多(Charlson 合并症指数≥2,优势比 1.32;95%置信区间,1.22-1.44);要么是医疗保险状态(1.84 [1.72-1.97])或医疗补助状态(1.60 [1.48-1.73])相对于私人保险;中度(1.09 [1.03-1.15])或重度(1.33 [1.13-1.56])相对于轻度全国再入院数据库提供的严重程度;非最初入院所在州的居民(1.49 [1.31-1.69]);出院到非家庭保健系统(1.70 [1.46-1.97]);短期住院 1.70 [1.46-1.97]);入住私立医院(1.11 [1.01-1.22])相对于非营利性医院;初始住院时间延长(1.81 [1.70-1.92]);以及指数入院期间发生严重不良事件(1.20 [1.02-1.42])。再入院的患者总费用的平均差异为 15781 美元(95%置信区间,15168-16394.4;P <.001)。
减重手术后的再入院率即使在出院后 6 个月仍持续存在。这些再入院大多与指数手术直接相关。近四分之一的再入院患者需要手术,近三分之一的患者前往与初始手术不同的医院。这些再入院给医疗保健系统带来了沉重的负担,并可能损害患者的生活质量。在这一人群中,有必要针对预防传统 30 天基准之外的再入院制定策略。